Latest News about Pablo Zuanic
Recent news which mentions Pablo Zuanic
Analysis: Aurora Cannabis Could Improve Position Based On Exports, Jushi Price Target Adjusted Down
October 05, 2021
From Benzinga
Cantor Lowers Price Target On Trulieve Post Harvest Merger Projecting Disrupted Near-Term Performance
October 04, 2021
From Benzinga
Which Canadian Cannabis Producer Is Best Positioned To Enter The US?
October 01, 2021
Tickers
CGC
From Benzinga
Is Aurora Cannabis' 'Business Transformation Plan' Yielding Results?
September 28, 2021
Tickers
ACB
From Benzinga
New Jersey's Legal Cannabis Roll Out Could Face Delays: Will Neighboring States Benefit And Pull Ahead?
September 27, 2021
From Benzinga
New York: The New Cannabis Capital? Sen. Liz Krueger To Lead 'Nation-Leading' Summit Later This Month
September 23, 2021
From Benzinga
Is Trulieve Still A Top Pick Ahead of $2B Harvest Health Merger?
September 22, 2021
From Benzinga
Canopy Growth's Exec Phil Shaer Steps Down As Head Of Legal Department
September 21, 2021
Tickers
CGC
From Benzinga
Canopy Growth's Stock Dips After Analyst Cuts Price On Lower Sales, Confesses Preference For Tilray
September 20, 2021
From Benzinga
Will Aurora Become A Global Medical Marijuana Leader? Analyst Opines Ahead Of Q4 Earnings
September 17, 2021
Tickers
ACB
From Benzinga
Analyst: Updating Tilray's Numbers Ahead Of Aug Qtr Print
September 16, 2021
Tickers
TLRY
From Benzinga
Why Should Cresco Labs Trade At A Premium To Its Peers?
September 09, 2021
Tickers
CRLBF
From Benzinga
Organigram On Pace To Beat Tilray And Hexo In QoQ Sales Growth As Canadian Rec. Sales Reach $275.6M
September 07, 2021
From Benzinga
From Benzinga
Trulieve Milestone: Opens 100th Cannabis Shop Nationwide, Gears Up Ahead Of Harvest Health Merger
August 25, 2021
From Benzinga
Why Are AYR Wellness And Verano Holdings Best Positioned For NJ's Recreational Cannabis Program?
August 24, 2021
From Benzinga
Should You Buy Trulieve Stock Before Its $2.1B Merger?
August 23, 2021
From Benzinga
Analyst Says MedMen's Momentum Changing, Tilray's Stake Won't Double Its Value But Will Hold Premium
August 18, 2021
From Benzinga
Cantor Fitzgerald Says Tilray's Stake In MedMen One Of The Steps In The 'U.S.' Journey, Could Be Getting Close To Altria
August 18, 2021
From Benzinga
Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science CBD Stocks, Sector Could Benefit From Federal Legalization
August 13, 2021
From Benzinga
Cantor Fitzgerald Remains 'Neutral' On Sundial Growers After Earnings Report, Sees Potential Upside In Its 'CA$1B War Chest'
August 13, 2021
From Benzinga
Cantor: 'Aleafia Continues To Post Solid Momentum,' Firm Bullish But Lowers Price Target Due To Cannabis Sector Derating
August 12, 2021
Tickers
ALEAF
From Benzinga
Cantor Is Bullish On Trulieve's Q2 Financials, But Remains Cautious Of Possible Risks Ahead, Drops Price Target To $50
August 12, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.